Scientific and clinical paperBacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
References (8)
- et al.
Pseudomonas pyocyanea in burns
Lancet
(1951) - et al.
Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics
J Gen Microbiol
(1982) - et al.
The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages
J Gen Microbiol
(1987) Treatment of experimental infections of mice with bacteriophages
J Med Microbiol
(1992)
There are more references available in the full text version of this article.
Cited by (107)
The role of biofilms and multidrug resistance in wound infections
2023, Bioengineered Nanomaterials for Wound Healing and Infection ControlBacteriophage interactions with mammalian tissue: Therapeutic applications
2019, Advanced Drug Delivery ReviewsCitation Excerpt :Phage therapy in experimental animal models holds an impressive record, but the penetrative and other pharmacokinetic parameters in human skin infections have not been extensively studied. Soothill et al. (1994) demonstrated the ability of lytic phages to permeate dead dermis to prevent skin graft destruction by P. aeruginosa [30]. Skin grafts of guinea pigs extending down to the subcutaneous fat was excised, and was inoculated with bacteria (106 CFU), followed by the replacement of the graft back to its initial position.
Immobilization of bacteriophage in wound-dressing nanostructure
2017, Nanomedicine: Nanotechnology, Biology, and MedicinePhage therapy: Clinical applications, efficacy, and implementation hurdles
2024, Open Microbiology JournalBacteriophages:An Alternative to Combat Antibiotic Resistance?
2022, Journal of Drugs in Dermatology
Copyright © 1994 Published by Elsevier Ltd.